Delivery Order SPE2DB20D3103-SPE2DB21FQ3L1
- Not listed
- This federal contract award is for the delivery of Glyburide-Metformin 5-500 mg, 100 count, to the Defense Logistics Agency (DLA). The contract, valued at $1,053.52, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,803.08 Firm Fixed Price delivery order is for the supply of Glyburide-Metformin 5-500 mg medication, with a performance period through May 25, 2023. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.38 Firm Fixed Price Delivery Order contract is for the supply of Glipizide-Metformin 2.5-500 mg tablets, a medication used to treat diabetes. The contract has a period of performance through July 1, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,968.16, is for the delivery of Glipizide-Metformin 5-500 mg tablets over a period ending on April 15, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,249.17 for the supply of Metformin HCl 500 mg tablets, a common medication used to treat diabetes. The contract does not have a set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB25FL8A6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,009.97, is for the delivery of Glipizide-Metformin 2.5-500 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and a ceiling value of $2,155.92. It is not designated as a set-aside contract. The contract provides for the delivery of GLYBURIDE-METFORMIN 5-500 MG 100S, a pharmaceutical product used for the treatment of diabetes. This Delivery Order is part of a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.56 Firm Fixed Price delivery order is for the supply of Metformin HCL ER 500 mg tablets, a medication used to treat type 2 diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $5,889.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566370509 - GLYBURIDE-METFORMIN 5-500 MG 100S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glyburide-Metformin 5-500 mg medication. The contract has a ceiling value of $23,674.31 and a period of performance through April 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., also...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ3L1Delivery Order
This federal contract award, valued at $1,160.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glyburide-Metformin 5-500 mg tablets, a medication used to treat diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/21 |